Why I Joined MDisrupt

Why I Joined MDisrupt

Kerry Amato

Kerry Amato, MDisrupt’s new VP of business development and partnerships, describes what drew her to MDisrupt from the Health Information and Management Systems Society (HIMSS).

MDisrupt: shaping the ecosystem

Being part of a startup was never on my career roadmap. But after nearly a decade at HIMSS—most recently as vice president (VP) for health innovation—I’ve joined MDisrupt as its VP of business development and partnerships. I did so because I believe MDisrupt is extremely well-positioned to shape the digital health ecosystem in ways that will benefit patients, providers, and health systems for decades to come.

Digital health products need evaluation

As the digital health market has exploded—with more than $20B invested in 2021—I’ve become increasingly interested in how we discover which of the thousands of innovations coming to market really work. Which ones actually improve patient experience, deliver ROI, and improve the health of a population? And how do we ensure that investments are going to the innovations that will actually have an impact?

Ensuring benefits for patients and providers

Let’s make it real: How does someone like my dad pick the right device for him, with confidence that it will work? What does he do when a product doesn’t meet his needs? How can he provide input into what would work for him?

On the provider side, sometimes the shiny new object on the market doesn’t actually solve real-world problems facing physicians. Instead, it may just add to the burdens of their day-to-day work. How can we channel their insights and their voices in a way that cuts through the noise and contributes to truly useful products and solutions?

MDisrupt’s mission of organizing the world’s digital health products by performance through clinically crowdsourced data generation is powerfully inspiring to me. I believe the company can help to ensure that the best products make it to market and are evaluated in ways that benefit healthcare as a whole.

MDisrupt: right people, right time

My favorite work “superpower” is connecting people. I love watching what happens when you put the right people together at the right time. I look forward to building long-lasting partnerships that not only disrupt healthcare but also change the way we think about innovation.

Meeting a team as dynamic as the one at MDisrupt, I felt I had no choice but to lean into the opportunity. The company’s core values—data-driven, truth-seeking, always objective, and people first—could have been written just for me. There is something very special about the MDisrupt team and I am thrilled to be part of the future of this organization.


If you want to dive into more healthcare topics, check out our blog at MDisrupt.

At MDisrupt, we believe that the most impactful health products should make it to market quickly. We connect digital health innovators to the healthcare industry experts and scientists they need to responsibly accelerate product development, commercialization, adoption, and scale.

Our experts span the healthcare continuum and can assist with all stages of health product development: This includes regulatory, clinical studies and evidence generation, payor strategies, commercialization, and channel strategies. If you are building a health product, talk to us.

The Theranos Verdict: In Healthcare, Money Should Follow Science

The Theranos Verdict: In Healthcare, Money Should Follow Science


MDisrupt CEO and founder Ruby Gadelrab on the best way for investors to avoid Theranos-style mistakes

“Move fast—responsibly.”

Silicon Valley has become known for its’ “go fast and break things” approach. But the core principle of healthcare is “do no harm.” However, one cannot safely, ethically or legally “fake it until you make it” when patients’ health and lives are at stake.

That’s one clear takeaway from the verdict that found Elizabeth Holmes, founder and former CEO of the health technology company Theranos, guilty on four counts of defrauding her investors about the company’s blood-testing technology.

From my perspective, it’s extremely unfortunate that Holmes was acquitted of four other counts of fraud involving patients who said they were deceived by Theranos’s claims. While investors were indeed deceived, they had the opportunity to look more closely at Theranos before investing. Patients who believed the company’s claims did not have that option. In this verdict, investors were vindicated, patients were not.

But in the rush to draw meaning from the verdict, let’s not assume that all digital health companies—or even most of them—are like Theranos. There are plenty of healthtech companies out there who are eager to go fast, responsibly—and plenty of investors willing to do the homework that Theranos’s investors skipped.

While healthcare is complex, highly regulated, and probably the hardest area in which to invest, there is a clear formula that investors can follow to avoid making costly—in every sense of the word—Theranos-style mistakes.

Invest in medical diligence

Investors routinely do technical and financial diligence using experts. When investing in healthcare technology companies, investors must also do medical diligence using healthcare experts. It’s a critical element of establishing whether a product is commercially and clinically viable.

The 5 elements of medical diligence

1) Does the technology actually work? This is often known as analytical validation or technology validation. Investors need to determine if there is evidence to back up the founders’ claims. And the marketing must be truthful. It is both unethical and illegal to overstate claims.

2) Show me the data! (Ask for the clinical validation data.) Does the technology actually pick up a disease or biomarker when it’s present—and not pick it up when it’s not there? Not all data are created equal. Good data are generated externally with scientists and research labs, great data are published in peer-reviewed journals, and excellent data are published and replicated. In the case of Theranos, every time they were asked for the data they claimed that they didn’t want to share their “trade secrets.” In healthcare you have to publish your studies and also submit them to regulatory bodies.

3) Evaluate the clinical utility. Ok, the technology works, and successfully detects what it is supposed to. But is the product clinically useful? Does it actually solve a real problem in healthcare or is it just technology for sake of technology looking for an application in healthcare? Will it actually change or impact the medical management of a patient? Is there buy-in from both health systems and healthcare providers?

4) Review the health economic data. How much does the technology cost to implement, and how much does it save the healthcare system compared to the standard of care? Will there be, or is there, Medicare, Medicaid, or private insurance reimbursement for the treatment or product?

5) Confirm legal and regulatory compliance. Has the founder evaluated all the laws and regulations that apply? Can the founders prove that the company and the technology are compliant with those laws? What is the reporting structure of the general counsel, the chief compliance officer, and/or the privacy officer? Are there any conflicts of interest with the same? Healthcare is one of the most regulated industries in the US, making healthcare compliance a crucial and growing field within the industry.

Look closely at company structure & culture

Make sure the RIGHT healthcare experts have a seat at the table and a strong voice in the process (and are not just there for show and credentials). There are a few important signals that can help investors determine whether this is happening.

For instance, does the company have physicians, scientists, or clinical experts within the team, or as investors? On the board of directors? What about as part of the C-suite or in senior positions? The most successful healthcare startups have a balance of clinical, commercial and tech skill sets. And ideally, a digital health company would have a chief medical officer and chief compliance officer on the executive team even in fractional roles. At MDisrupt, one of our specialties is matching vetted healthcare industry experts with digital health startups so they can access all the essential skills they need, on demand.

Company culture is also important. Talk to the employees—do they see a culture of silence and secrecy, or one of transparency and collaboration? One red flag: When there is high turnover in scientific, clinical, or compliance positions, a company is in trouble. (I know this because many such individuals join our expert network at MDisrupt. In fact, often the culture is so bad that they leave the company before they have other jobs.)

Don’t assume all healthtech startups are like Theranos

Every day I meet incredible truth-seeking founders and who are building life-changing health technology products. Unfortunately and unfairly, many are being greeted with skepticism in the shadow of Theranos—particularly women founders, lab testing companies, and companies focusing on point of care and blood collection devices. Yet all it takes is some medical diligence to be able to separate the truth-seekers from the rest.

Involve experts from the start

Engaging the right experts early and often in the development of a health product can be the key to adoption and scale within a healthcare setting. By building collaborative partnerships between digital health and health industry experts, we can get the best of both worlds.

If you want to dive into more interesting topics related to healthcare, check out our blog at MDisrupt.

At MDisrupt, we believe the health products with the most potential to do good in the world should make it to market quickly. We help make this happen by connecting ambitious digital health innovators to the healthcare experts who have the skills they need most.


Our experts span the healthcare continuum and can assist with all stages of health product development: This includes regulatory, clinical studies and evidence generation, payor strategies, commercialization, and channel strategies. If you are building a health product, talk to us.

Why I Joined MDisrupt

Why I Joined MDisrupt

Chet Robson

Seasoned healthcare veteran Chet Robson, DO, MHCDS, FAAFP, explains his move from big pharmacy chain to early-stage startup.

From Walgreens to MDisrupt

Last month, I made a huge career shift. I left my position as chief clinical officer of Walgreens—a multibillion-dollar corporation—to become chief medical officer at MDisrupt, a platform company connecting digital health companies with healthcare experts. MDisrupt is a startup that’s just two years old. As might be expected, I was asked a lot of questions, usually some variation of “Why MDisrupt? Why now?”

Here’s why.

Evidence matters

During my seven years at Walgreens, my team and I evaluated thousands of companies, programs, devices, products, and services, assessing their potential value to our millions of customers. Our goal was to ensure that clinical risk was minimized, and clinical benefits maximized, for every solution that Walgreens made available.

Central to this effort was an evidence-based review process I developed, drawing on evidence-based medicine as well as on healthcare device and product assessment methodologies. We focused on evaluating healthcare products and services through the lens of several key questions, among them: What is the nature of the evidence supporting this solution? Does the product or service measurably affect outcomes? Is it appropriate and cost-effective for its intended use?

It’s not easy for an individual, a company, an employer, a payer, or a researcher to discern the answers to these questions. But it’s essential—especially given the explosion of innovation from many different sectors (tech, payers, pharma, government, delivery systems, providers, and patients) seeking to improve healthcare. And now that the pandemic has accelerated the development of digital health, assessing the evidence and performance of these solutions has become increasingly urgent, as this article in Health Affairs makes clear.

Building better health products together

Several years into my work at Walgreens, MDisrupt’s launch announcement caught my attention. MDisrupt’s mission is to ensure that the most impactful health products make it to market both quickly and responsibly. The company connects digital health innovators to the scientists and healthcare industry experts that they need to optimally build, commercialize, and scale health products. I thought at the time that linking these two sectors was a fantastic way to build better solutions than either sector could create on its own. And I paid attention as the company grew, assembling a highly talented network of health care experts in a short period of time.

What really convinced me to become part of MDisrupt, though, was meeting Ruby Gadelrab and Ragan Hart, the company’s co-founders. I knew that each brought impressive credentials and accomplishments from their past roles: Ruby’s experience as an executive with Affymetrix, Invitae, and 23andMe, and Ragan’s PhD in health economics and Masters in public health genetics were a wonderful complement to my background as a physician, chief medical information officer, and chief clinical officer. The synergies were obvious, and our initial conversations always extended well beyond the allotted time.

The more we talked, the more clear it became to me that joining MDisrupt would be an opportunity to apply my expertise across a wide range of healthcare sectors. And so I decided to make the leap.

The MDisrupt advantage

MDisrupt is uniquely resourced and positioned not only to meet the needs of many healthcare startups, but also to reduce risk and optimize opportunities for established healthcare entities that are now innovating and evolving. MDisrupt is already providing services to a diverse range of entities: digital health startups, labs, payers, pharma, contract research organizations, health systems, biotech, and delivery model innovators. And although MDisrupt is based in Austin, Texas, over 25% of the company’s business is with global companies headquartered outside the US: in the UK, Spain, Italy, and Brazil, to name a few.

It’s no exaggeration to say that I’m thrilled with my new role. My colleagues at MDisrupt share my belief that innovation requires knowledge, creativity, and absolute customer/patient focus to produce useful, effective products. Together, I believe we can play a significant and meaningful role in transforming healthcare for the better.


If you want to dive into more healthcare topics, check out our blog at MDisrupt.

At MDisrupt, we believe that the most impactful health products should make it market quickly. We connect digital health innovators to the healthcare industry experts and scientists they need to responsibly accelerate product development, commercialization, adoption, and scale.

Our experts span the healthcare continuum and can assist with all stages of health product development: This includes regulatory, clinical studies and evidence generation, payor strategies, commercialization, and channel strategies. If you are building a health product, talk to us.

Getting Physicians Involved in Digital Health

Getting Physicians Involved in Digital Health

Ben Schwartz, MD

Meet Ben Schwartz, MD, an orthopedic surgeon who’s dived into digital health.

podcast available

Dr. Schwartz is a board-certified orthopedic surgeon specializing in surgical and non-surgical treatment of hip and knee arthritis. He has extensive experience in digital health and serves as a chief innovation officer for Healent, an early-stage healthcare technology company. He also holds mentorship positions with incubators and accelerators, as well as advisory roles. He’s a prominent voice on LinkedIn and other social media platforms.

The Promise of Technology

MDisrupt: What got you interested in digital health?

Ben Schwartz: I had a pretty traditional practice for the first 10 years of my career. I’ve always been fascinated by computers and gadgets and new ways of doing things. About two or three years ago, I became aware of this whole world of digital health, which was maturing. We have this healthcare system that doesn’t work in a lot of ways. We have technology that works in other aspects of our lives, but we’re not really utilizing it well in healthcare. How do we adopt technology in healthcare to make things better?

MDisrupt: You’re a top voice on LinkedIn and your posts really get the conversation started. What impact do you think you’ve had?

Ben Schwartz: When I started to become interested in this, I was your traditional orthopedic private practice surgeon outside of a major metropolitan area. I didn’t necessarily come across people in digital health. LinkedIn became a great way to open doors.

MDisrupt: You wrote, “Big tech doesn’t need healthcare. Does healthcare need big tech?” What’s your answer?

Ben Schwartz: I don’t think healthcare necessarily needs big tech. We know healthcare needs to do a better job incorporating technology, because we lag behind other industries. I do think big tech has the potential to address a lot of issues in healthcare, from an access as well as a technological standpoint. You’re talking about some of the biggest, most resource-rich companies in the world and one of the biggest problems we’re facing, not just in this country, but in the entire world. 

Google and Apple have shown interest in healthcare. Whether that persists I don’t know. The clinics that Apple supposedly was trying to open up were really fascinating—it’s disappointing to hear that maybe that didn’t work. Amazon is doing their typical approach of starting slowly and testing use cases and gradually building. 

“Digital health tools are coming”

MDisrupt: What kind of trends are you seeing among your colleagues around innovation in healthcare?

Ben Schwartz: There are definitely pockets of physicians who are very innovation-minded. And then you have more traditional physicians who are just so busy that when they hear about technology and innovation, they roll their eyes and equate it with the EMR that’s just going to make their lives more complicated. Or they think that it’s hard to prove the use case or the value. But more and more we’re seeing physicians who are entrepreneurial who are either going to come up with their own solutions or work with companies who embrace solutions. I think that’s going to become the norm.

And if you are a physician who’s resistant to technology or innovation, now is the time to reconsider. Because artificial intelligence is coming, these health tools are coming. Patients are going to want them, health systems are going to start embracing them. The future may belong to physicians who are more innovative and entrepreneurial and embrace these things.

Consult clinicians early and often

MDisrupt: Say you were at dinner with a digital health entrepreneur, and they ask, “What do I need to consider to get my product to market?” What would you tell them?

Ben Schwartz: It’s a matter of addressing true pain points. If you don’t have experience in real-world healthcare, you may say, “Oh, I have this great product that addresses this pain point.” But if you don’t understand how healthcare is actually delivered, there are barriers you may not have considered. It’s important to make sure your solution really can be incorporated into a workflow. And how do you prove return on investment? How do you monetize it?

These are the things you want to figure out early on. A great way to do that is incorporate people who have real-world experience early on in the process. Start building your clinical team early on so you don’t get too far down the road in the wrong direction and have to start over.

MDisrupt: Bridging that gap can be pretty difficult.

Ben Schwartz: It’s a challenge. Most physicians are not on an island where they can make unilateral decisions. So how do you incorporate it into a hospital, or a health system, a physician practice, and get everybody on board? If there’s one person who puts up resistance, that can table the whole thing. There’s not an easy answer. It’s a challenge that digital health companies face and that’s why often they go to an employer or a payer, because it’s easier to make traction there.

We need physicians involved and using these products. At the end of the day, a lot of times physicians or patients are the end users, but they’re not necessarily seen as the way forward for these ideas to really gain traction and be viable.

The growing network of physician innovators

MDisrupt: Can you describe the doctor innovator phenotype?

Ben Schwartz: They are people who aren’t satisfied with the status quo. But rather than just decrying the challenges or feeling burnt out, they think, “There’s a problem, let’s figure out a way to solve it. Maybe I can design my own solution, maybe I can partner with somebody who’s developing a solution.” Those people are out there—on Twitter, on LinkedIn, at hackathons. They’re doing advisory work and they’re joining digital health companies.

MDisrupt: Is that phenotype fostered in medical school?

Ben Schwartz: The current generation of doctors in medical school are very tech savvy. They are learning about this stuff in medical school. I get so many young medical students or residents who reach out to me and say, I have an interest in this, how do I get involved? Which is great to see because that’s really going to help adoption. You’re going to have people who are innately willing to embrace this, with the medical background to guide the development of these solutions.

What’s essential to a health innovation?

MDisrupt: When you look at a new health product, how do you evaluate what’s important?

Ben Schwartz: Number one, does the health product really bring something new to the table? Does it solve a problem? Does it bring something that’s clinically relevant, clinically validated? Is it something that can be easily incorporated into a workflow, as opposed to a piece of technology that’s making things more complicated? To me, the best technology is elegant, it works in the background, or it integrates very seamlessly into what you’re already doing. And then it really makes meaningful change. 

And again, unfortunately with the reality of our system, there’s got to be some eye towards return on investment and how do you make sure that this is something you can incorporate and it’s not cost-prohibitive or bring something to the table from a value standpoint.

MDisrupt: Do you see a lot of positive headlines around the pandemic having helped to bolster digital health? 

Ben Schwartz: My concern is that as we—hopefully—move to a post-pandemic environment, [we examine] Did we go too far towards telehealth? I worry that there’s an overcorrection. There are certain things that telehealth or virtual solutions aren’t going to be able to address. And some patients really do want that traditional doctor-patient relationship. It doesn’t have to be for everything, and maybe healthcare technology and digital health can replace some of the inefficient, expensive things we’re doing. But at the end of the day, the doctor-patient relationship is at the core of healthcare. 

Top innovative US health systems leading the way

MDisrupt: You wrote, “If you’re developing a tech-enabled healthcare solution and counting on physicians to embrace it, this issue should be front and center in your product design and go-to-market strategy.” MDisrupt is connecting innovators with clinical experts. Do you see health innovators trying to get clinical early adopters to use the technology before it’s out there?

Ben Schwartz: You have to find the individuals willing to embrace it. And there is, as far as I know, no central resource of a list of hospitals, health systems, physicians that are open to this kind of thing. And there are so many companies out there—the same people can’t be trying to adopt 50 different tools because they’re known as more forward-thinking. So I think it’s coming, I think it’s slow. I think hospitals and health systems are realizing that they have to get on board with healthcare technology and innovation. I don’t think they know exactly yet how best to do that. Some of the more innovative health systems like Stanford, Intermountain Healthcare, Cleveland Clinic, Mayo Clinic will really be the leaders on that. And then it will diffuse out to the rest of the system.

Digital tools supporting traditional healthcare

MDisrupt: What is your dream digital health tool for orthopedics?

Ben Schwartz: Orthopedics is procedure-focused. A lot of the innovation happens [around] surgical robots, or tools and equipment that we can use in the operating room. We’re seeing a shift towards value-based care. Hip and knee replacements are so commonplace and cost, particularly Medicare, a lot of money. We’re understanding that we have to do a better job of preparing patients for surgery, making sure they’re healthy enough for surgery, and making sure they understand the process of recovery. I think we are going to see educational tools like we’re trying to build with Healent. I think we’re going to see post-operative remote patient monitoring tools so that we can keep a close enough eye on patients to identify a problem and intervene earlier.

I think we will see more innovation outside the operating room in orthopedics as we see more adoption of value-based care. It’s about preparing people for treatment and also supporting them afterward. Digital health can fill that void.

MDisrupt: What does a doctor-patient relationship look like today? And what will it look like in the future?

Ben Schwartz: It gets frustrating sometimes to hear about how so-called traditional physicians are really bad at their job.  If you’re outside that system, it’s easy to throw stones. But there are people on the front lines fighting these battles and doing the best they can within the system.

The doctor-patient relationship has been eroded over the last 20 years by things like EMRs, increasing administrative hoops to jump through, declining reimbursement, and increasing overhead. That doesn’t get enough attention from digital health—can we build tools to [bolster] that doctor-patient relationship? Whether it’s through documentation, natural language processing, or a better EMR, it would be great to see more of those tools come to light. Let’s build tools that really support what works about traditional healthcare, restore that doctor-patient relationship and focus on those physicians that are willing to evolve and be agents of change.

At MDisrupt we believe that the most impactful health products should make it to market quickly. We connect digital health innovators to the healthcare industry experts and scientists they need to responsibly accelerate product development, commercialization, adoption, and scale.

Our experts span the healthcare continuum and can assist with all stages of health product development: regulatory, clinical studies and evidence generation, payor strategies, commercialization, and channel strategies. If you are building a health product, talk to us.

And check out our blog and services!

6 Big Themes from HLTH 2021

6 Big Themes from HLTH 2021

Mona Schreiber

Our team chose HLTH 2021 as our first conference to attend since the pandemic began. It was a fantastic experience—here are 6 big takeaways.

Practicing clinicians need to be here

What’s the easiest way to get a digital health solution adopted into clinical practice? Solve a real challenge, integrate seamlessly into the clinical workflow, and enhance both patient and clinician experience (we’re taking “Do no patient harm” as a given). This might sound like a lot to strive for, but all these elements are essential. We noticed that the majority of panels and conversations at HLTH were among entrepreneurs and CXOs. While medical expertise was showcased, we didn’t hear from many practicing clinicians who see patients day in and day out about their perspectives on these trends and solutions. We at MDisrupt know that involving clinicians early and often in your healthcare solution yields better and faster adoption. So let’s stop discussing healthcare in silos and make sure all stakeholders have a seat at the table and a voice in the process of digital health development. We’re all united in addressing the same challenges.

Health equity is on everyone’s mind

New health care delivery models like telemedicine are here to stay—entrepreneurs at HLTH made that very clear. Many top payers have even announced virtual-care-specific plans to be launching soon. That’s great for those with reliable internet connection who know how to use technology. But conversations among entrepreneurs and payers revolved around how to reach those who haven’t been reached yet, to enable a more inclusive experience. This included discussions on payment models beyond self-pay and  ways to reduce barriers to health literacy based on socio-economic background. From our perspective, the conversations around health equity are important—but now it’s time to move beyond conversation and into action. 

Implementing available solutions into the current system is hard

Right now, consumers have access to a plethora of digital health solutions. But there’s a huge gap between what consumers can access and what actually gets used and is clinically useful in the healthcare setting. Furthermore, the consumer/patient experience becomes very disjointed once they bring digital health solutions to healthcare providers with no knowledge or experience of these solutions. Often the potential health outcomes and the ROI of the solution are not clear. The current solution for this is that the big players in healthcare like to test solutions with ‘Pilots” However the term “death by pilot” was heard a lot during HLTH. Our favorite quote came from Chrissy Farr’s interview with Alan Lotvin MD, who is EVP of CVS Health; he said, “Big companies in healthcare like to torture small companies.”

Payers, providers, health systems, and employers all agree that we need a better system of vetting evidence based digital health solutions. How do we solve this? At MDisrupt, we believe that missing from our industry is a unified standards system for digital health to assess the real-world clinical performance of these products. We intend to focus on this monumental challenge over the next few years.

Healthcare’s tech shift was super-accelerated by the pandemic

This was the first conference we’ve attended where a testing protocol was implemented at the conference. Every single person who attended had to be tested. And we have to credit HLTH, as the process was relatively fast and efficient. Deployment happened through an app, human guides helped us through the process, and an onsite testing system delivered results to us in 20 minutes via our apps. This is a demonstration of just how far we have come in digital health in just two years. It showed us that we can bring lab testing closer to the consumer at scale, we can make it more efficient and more convenient, we can take care of people where they live and where they work. Now that we know it can be done, imagine if this could be applied to all areas of healthcare!

Mental health is no longer an afterthought

The pandemic changed the way we think and talk about mental health. Treatment and services for conditions that were once stigmatized, with care available primarily for severe cases, are now becoming part of the norm. . Leaders in mental and behavioral health came together at HLTH to discuss improving delivery models, like telemedicine; integrating mental health practices into a complete healthcare plan, and, best of all,making these changes mainstream. There’s still a long way to go in reaching the masses, but it was clear that technology can make it happen.

The need for human connection is so real

As we registered for HLTH, we were asked to choose a wristband that signaled how you wanted to be greeted:

  • Green bands signaled that you were ok with hugs and handshakes
  • Yellow bands signaled that you preferred fist elbow bumps
  • Red bands signaled a no touch-greeting.

By the end of the first day, the basket of green bands was completely empty, with the majority of us selecting them. After two grueling pandemic years—in which many of us have been in lockdown and seen the suffering and loss of many people close to us—it was clear how much we all needed human contact. There was a lot of welcome hugging and handshaking as folks who hadn’t seen each other for over two years reconnected. The unspoken feeling between us was that we are all in this together, and that we are the changemakers for a better future.

To quote this year’s HLTH motto: ”Dear Future, we are coming for you.”

If you want to dive into more interesting topics related to healthcare, check out our blog at MDisrupt.

At MDisrupt, we believe that the most impactful health products should make it market quickly. We connect digital health innovators to the healthcare industry experts and scientists they need to responsibly accelerate product development, commercialization, adoption, and scale.

Our experts span the healthcare continuum and can assist with all stages of health product development: This includes regulatory, clinical studies and evidence generation, payor strategies, commercialization, and channel strategies. If you are building a health product, talk to us.

Why No Digital Health CEO Should Miss HLTH

Why No Digital Health CEO Should Miss HLTH

Mona Schreiber

Didn’t go to the HLTH conference? Don’t know why you should have been there? MDisrupt’s VP of Marketing Mona Schreiber shares her take on why it offers incredible opportunity for digital health CEOs.

You’re a digital health CEO, building a rockstar team, staying on top of industry trends, raising capital, and trying to keep the lights on. We get it. You’re busy! 

MDisrupt was there. We’re also a startup in the digital health space and our CEO barely sleeps because she’s navigating the same challenges. Why did we take time out of our schedules to be there? 

MDisrupt breaks it down for you:

See the latest trends

If you’re like us, you subscribe to several different newsletters/news sites to keep up on the latest trends, but never have time to read anything beyond the same two or three headlines you see pop up in your social media feeds. The HLTH conference is a three-day immersion in all the trends in digital health, the perspectives of the various healthcare stakeholders, what the future holds, and how not to be left behind. It’s like a “bootcamp into the healthcare of the future.” You can leave here more informed than if you sat down and read every single article that came out. And… it’s so much more fun this way! 

Network with other entrepreneurs

Ever ask the question – how did my peer/ Entrepreneur X solve that problem? At HLTH, you can ask them! This conference is full of founders who have walked the path before you and advisors who are ready to help others. You’re not alone. You’ll be able to meet hundreds of other digital health companies disrupting the healthcare space, all at one venue. No more googling leading you down a rathole. Meet the amazing minds behind each innovation, in person.

Meet the investors

Flying around the country to meet with individual investors isn’t the most ideal way to fundraise – especially in the middle of a pandemic. This year’s HLTH had something unusual about it that we had never seen before. The digital health space is so hot right now that investors set up booths in the exhibit hall. In fact, there were 70+ investment partners in attendance.  And they partied hard – every night the bar at the Omni was overtaken by our investor friends.  No more waiting for warm intros – HLTH was the place to be if you wanted to meet investors in a more casual setting. For now, it’s a founders market. 

Bolster your team

The team you build is the essence of your company, particularly in complex spaces like healthcare.  You need to hire amazing talent and fast – the story of every startup. What if there was a place you could go to meet these people without hiring someone to scour LinkedIn all day? Meet them all in one place. Even better, meet connectors – like MDisrupt – who can help you find the expertise you’re looking for, quickly and on demand. 

Get inspired!

It’s been a year. You and your team have accomplished so much, but you’re mentally and emotionally exhausted. There’s only so far coffee can go. What if you could meet the patients whose lives you were changing with your innovation? Bet that would get your emotional mojo going.

This conference oozes creativity in solving healthcare challenges. Our team came back with more energy and ideas after meeting and exchanging ideas with the most passionate minds in healthcare. Be there! Feel the energy. Reset. Crush it!

You missed the conference, so what now?

Step 1: Sign up for a free 30-minute consultation to discuss a project you’re working on – we have over 250 health experts who can help you tackle your challenge.
Step 2: Follow us on Linkedin and Twitter.

See you there next year!

If you want to dive into more interesting topics related to healthcare, check out our blog at MDisrupt.

At MDisrupt, we believe that the most impactful health products should make it market quickly. We connect digital health innovators to the healthcare industry experts and scientists they need to responsibly accelerate product development, commercialization, adoption, and scale.

Our experts span the healthcare continuum and can assist with all stages of health product development: This includes regulatory, clinical studies and evidence generation, payor strategies, commercialization, and channel strategies. If you are building a health product, talk to us.